6-83853456-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001009994.3(RIPPLY2):c.40G>T(p.Ala14Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,542,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001009994.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPPLY2 | NM_001009994.3 | c.40G>T | p.Ala14Ser | missense_variant | 1/4 | ENST00000369689.6 | NP_001009994.1 | |
RIPPLY2 | NM_001400900.1 | c.40G>T | p.Ala14Ser | missense_variant | 1/3 | NP_001387829.1 | ||
RIPPLY2-CYB5R4 | NR_174604.1 | n.97G>T | non_coding_transcript_exon_variant | 1/18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000443 AC: 6AN: 135568Hom.: 0 AF XY: 0.0000407 AC XY: 3AN XY: 73638
GnomAD4 exome AF: 0.0000151 AC: 21AN: 1390202Hom.: 0 Cov.: 32 AF XY: 0.00000875 AC XY: 6AN XY: 685738
GnomAD4 genome AF: 0.000282 AC: 43AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.40G>T (p.A14S) alteration is located in exon 1 (coding exon 1) of the RIPPLY2 gene. This alteration results from a G to T substitution at nucleotide position 40, causing the alanine (A) at amino acid position 14 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 14 of the RIPPLY2 protein (p.Ala14Ser). This variant is present in population databases (rs372681617, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with RIPPLY2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1361357). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at